Otax S 250mg/125mg Injection
Marketer
Swiss Pharma Pvt Ltd
Salt Composition
Cefotaxime (250mg) + Sulbactam (125mg)
Overview Otax S 250mg/125mg Injection
Otax S Injection (250mg/125mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth and propagation. Administration must always be under a doctor's direct supervision; strict adherence to the prescribed dosage schedule is crucial. Completing the full course of treatment is essential, even with symptom improvement, as premature cessation might compromise effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening of any side effect warrants immediate medical attention. Seek immediate medical help if allergic reactions (rash, itching, swelling, breathing difficulties) occur. Prior to commencing treatment, inform your physician about all current medications and any pre-existing health issues. Pregnant or lactating individuals require specific medical consultation before use. Alcohol consumption should be avoided due to the potential for increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, nutritious food, and sufficient hydration are recommended to facilitate recovery. Your doctor may order lab tests to monitor the medication's impact on your body.
Uses of Otax S 250mg/125mg Injection
Managing bacterial infections
Major Benefits of Otax S 250mg/125mg Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Otax S 250mg/125mg Injection:
- Injection site reactions (pain, swelling, redness)
- Injection site pain
- Injection site inflammation
- Hardening at the injection site
- Injection site tenderness
- Hypersensitivity
- Gastrointestinal disorder
- Decreased white blood cell count (neutrophils)
How to use Otax S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Otax S 250mg/125mg Injection works:
Otax S Injection, containing 250mg Cefotaxime and 125mg Sulbactam, combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Cefotaxime's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial growth. Sulbactam's role is to counteract bacterial resistance mechanisms, optimizing Cefotaxime's effectiveness.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Otax S 250 mg/125 mg Injection with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The injectable medication Otax S, containing 250 mg/125 mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Otax S (250 mg/125 mg) poses no known breastfeeding risk. Research in humans indicates negligible transfer into breast milk, thus presenting minimal hazard to the infant.
DrivingUNSAFE
Administration of Otax S 250 mg/125 mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
Individuals with impaired kidney function should use Otax S 250 mg/125 mg Injection cautiously. Dosage modification might be necessary. Physician consultation is recommended. Routine monitoring of renal function during treatment is advisable.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Otax S 250 mg/125 mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Otax S 250mg/125mg Injection :
Should you forget a scheduled dose of Otax S 250 mg/125 mg Injection, seek your physician's advice.
Facts to Know About Otax S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently